Another DPP4 inhibitor, saxagliptin, was reported to alleviate airway inflammation in ovalbumin (OVA)-induced asthma in mice via the NF-κB and TLR4 pathways (Helal et al., 2019). This evidence concerns the gene DPP4 and asthma.